Polaryx Therapeutics, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 13, 2026 | Raymond James | initiate | — → Strong Buy | — | 54% |
| Jul 27, 2026 | LUCID CAPITAL MARKETS | initiate | — → Buy | — | 34% |
| Jul 9, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
| Feb 27, 2026 | Maxim Group | initiate | — → Buy | $10 | 42% |
No cross-platform signals in the last 90 days